Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.50% | $155.66M | €439.05B | 57.00% | 76 Outperform | |
| Roche Holding AG | 1.44% | $89.95M | CHF276.02B | 52.12% | 73 Outperform | |
| AstraZeneca | 1.41% | $88.11M | £217.47B | 28.47% | 80 Outperform | |
| HSBC Holdings | 1.38% | $85.91M | £212.42B | 49.75% | 80 Outperform | |
| Toyota Motor | 1.29% | $80.42M | ¥48.41T | 26.98% | 80 Outperform | |
| Novartis AG | 1.28% | $79.82M | CHF217.88B | 29.42% | 80 Outperform | |
| Nestlé SA | 1.19% | $73.84M | CHF193.54B | 15.42% | 71 Outperform | |
| SAP SE | 1.17% | $72.98M | €234.09B | -20.72% | 66 Neutral | |
| Siemens | 1.07% | $66.64M | €203.53B | 29.34% | 74 Outperform | |
| Mitsubishi UFJ Financial Group | 1.03% | $64.33M | ¥33.14T | 62.55% | 76 Outperform |